Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

215.41 -4.12 (-1.88%)
Streaming Delayed Price Updated: 10:06 AM EST, Jan 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
News headline image
What's going on in today's session: S&P500 movers ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Mr Wonderful Kevin O'Leary Says Bitcoin, Ethereum Enough To 'Capture The Promise' Of Crypto, Advises Against 'Irrelevant' Tokens ↗
Renowned investor Kevin O’Leary expressed his belief on Wednesday that owning only Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) can capture the majority of the cryptocurrency market’s volat 
Via Benzinga
News headline image
Charles River Laboratories Announces Chief Financial Officer Transition
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Unpopular Stocks That Concern Us
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Breaking Down Charles River: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
2 Cash-Producing Stocks Worth Your Attention and 1 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
1 S&P 500 Stock with Exciting Potential and 2 We Brush Off
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
News headline image
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
These S&P500 stocks are gapping in today's session ↗
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Is the Market Bullish or Bearish on Charles River? ↗
 
Via Benzinga
News headline image
1 Profitable Stock with Promising Prospects and 2 We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
Peter Thiel-Backed Bullish Shoots Up 11% After-Hours Following Blockbuster IPO ↗
Shares of cryptocurrency exchange Bullish soared over 11% in Wednesday's after-hours trading following the company's successful Wall Street debut. 
Via Benzinga
News headline image
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
News headline image
CRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised Outlook
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit... 
Via StockStory
Topics World Trade
News headline image
Charles River (CRL) Q2 EPS Jumps 11% ↗
Via The Motley Fool
News headline image
Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing ↗
Charles River lifts earnings guidance after Q2 beat, citing biotech demand stability, solid DSA performance, and easing regulatory headwinds. 
Via Benzinga
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Charles River Laboratories (NYSE:CRL) Delivers Impressive Q2
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit... 
Via StockStory
News headline image
Charles River Laboratories Announces Second-Quarter 2025 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories (CRL) Reports Earnings Tomorrow: What To Expect
Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market open. Here’s what to look for. 
Via StockStory
News headline image
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.